.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Citi
UBS
Accenture
US Army
Johnson and Johnson
Fish and Richardson
Teva
Deloitte

Generated: November 21, 2017

DrugPatentWatch Database Preview

ENOVID Drug Profile

« Back to Dashboard

What is the patent landscape for Enovid, and when can generic versions of Enovid launch?

Enovid is a drug marketed by Gd Searle Llc and is included in one NDA.

The generic ingredient in ENOVID is mestranol; norethynodrel. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethynodrel profile page.

Summary for ENOVID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc
ENOVID
mestranol; norethynodrel
TABLET;ORAL010976-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Gd Searle Llc
ENOVID-E
mestranol; norethynodrel
TABLET;ORAL-20010976-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Gd Searle Llc
ENOVID
mestranol; norethynodrel
TABLET;ORAL010976-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Gd Searle Llc
ENOVID
mestranol; norethynodrel
TABLET;ORAL-20010976-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Gd Searle Llc
ENOVID-E 21
mestranol; norethynodrel
TABLET;ORAL-21010976-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Covington
AstraZeneca
Julphar
Deloitte
Dow
McKesson
QuintilesIMS
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot